Published in Br J Radiol on December 01, 1980
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. Br J Cancer (1984) 1.11
Development of drug resistance in a murine mammary tumour. Br J Cancer (1985) 0.96
Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds. Br J Cancer (1982) 0.88
Clonal variation in the sensitivity of B16 melanoma to m-AMSA. Br J Cancer (1982) 0.84
Response to continuous irradiation (CI) in relation to the initial slope of the cell survival curve for tumours and bone marrow. Br J Cancer Suppl (1984) 0.77
Radiation survival of murine and human melanoma cells utilizing two assay systems: monolayer and soft agar. Br J Cancer (1988) 0.75
Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Br J Cancer (1977) 2.31
UKCCCR guidelines for the welfare of animals in experimental neoplasia. Lab Anim (1988) 1.95
Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors. Br J Cancer (1978) 1.77
Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Br J Radiol (1974) 1.77
Electrogenesis in mouse neuroblastoma cells in vitro. J Cell Physiol (1971) 1.66
5-fluorouracil metabolism monitored in vivo by 19F NMR. Br J Cancer (1984) 1.56
Cellular radiosensitivity and DNA damage in primary human fibroblasts. Int J Radiat Oncol Biol Phys (1994) 1.55
The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother Oncol (1994) 1.54
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. Br J Cancer (1977) 1.51
Multiple sclerosis with clinical and radiological features of cerebral tumour. J Neurol Neurosurg Psychiatry (1982) 1.45
Electrophysiologic study of cultured neurons dissociated from spinal cords and dorsal root ganglia of fetal mice. Dev Biol (1973) 1.42
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer (1974) 1.35
The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer (1973) 1.33
Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br J Cancer (1977) 1.31
Cell yield and cell survival following chemotherapy of the B16 melanoma. Br J Cancer (1978) 1.30
The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer (1994) 1.23
Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazole. Br J Cancer (1981) 1.23
Electrotonic structure and specific membrane properties of mouse dorsal root ganglion neurons. J Neurophysiol (1981) 1.16
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16
DBS and diathermy interaction induces severe CNS damage. Neurology (2001) 1.12
Hypoxic cell sensitization by misonidazole in vivo and in vitro. Br J Radiol (1978) 1.12
Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. Br J Cancer (1984) 1.11
The dose-rate effect in human tumour cells. Radiother Oncol (1987) 1.10
Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 1.09
Dose-rate effects and the repair of radiation damage. Radiother Oncol (1986) 1.09
Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan. Br J Cancer (1978) 1.09
Morphology of dissociated hippocampal cultures from fetal mice. Brain Res (1979) 1.07
Effect of gamma radiation at high- and low-dose rate on a novel in vivo mutation assay in mouse intestine. Mutagenesis (1989) 1.07
Deformity of the labyrinth and internal auditory meatus in congenital deafness. Br J Radiol (1975) 1.06
Schistosoma mansoni in the spinal cord: a correlation between operative and radiological findings. J Neurol Neurosurg Psychiatry (1987) 1.06
Normal tissue radiosensitivity--how important is it? Clin Oncol (R Coll Radiol) (1996) 1.06
The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s. Int J Radiat Biol (1989) 1.05
The incidence of lung metastases in C3H mice after treatment of implanted solid tumours with x-rays or surgery. Br J Cancer (1974) 1.05
A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties. Int J Radiat Biol Relat Stud Phys Chem Med (1978) 1.05
Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes. BMJ (2000) 1.04
The relationship of DNA double-strand break induction to radiosensitivity in human tumour cell lines. Int J Radiat Biol (1990) 1.04
Skin reactions in mice after multifraction x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1974) 1.03
Effect of environmental temperature on the kinetic properties of goldfish brain choline acetyltransferase. Biochem J (1972) 1.03
The effect of radiation on tumour growth delay, cell survival and cure of the animal using a single tumour system. Br J Radiol (1977) 1.02
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Br J Cancer Suppl (1978) 1.02
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur J Cancer (1995) 1.02
Orthotopic liver homotransplantation: coagulation and hematologic changes in the pig. Arch Surg (1968) 1.01
The 5Rs of radiobiology. Int J Radiat Biol (1989) 1.00
Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase. Clin Cancer Res (1997) 1.00
Potentiation in vivo of melphalan activity by nitroimidazole compounds. Int J Radiat Oncol Biol Phys (1982) 0.99
RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions. Biochem Pharmacol (1986) 0.98
A panel of human lung carcinoma lines: establishment, properties and common characteristics. Br J Cancer (1987) 0.97
Radiosensitization in vivo: a study with an homologous series of 2-nitroimidazoles. Int J Radiat Biol Relat Stud Phys Chem Med (1983) 0.97
Clonogenic assays in the B16 melanoma: response to cyclophosphamide. Br J Cancer (1977) 0.97
Responses of neuroblastoma cells to iontophoretically applied acetylcholine. J Cell Physiol (1971) 0.97
The technique of orthotopic liver homotransplantation in the pig. J Surg Res (1968) 0.96
Development of drug resistance in a murine mammary tumour. Br J Cancer (1985) 0.96
Wiring in the treatment of aortic aneurysms. Br J Surg (1968) 0.95
Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother Oncol (1990) 0.95
Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582. Br J Radiol (1976) 0.95
RSU 1069, a 2-nitroimidazole containing an alkylating group: high efficiency as a radio- and chemosensitizer in vitro and in vivo. Int J Radiat Oncol Biol Phys (1984) 0.94
Proceedings: Mechanism of action studies with IRCF 159: effects on the growth and morphology of BHK-21S cells. Br J Cancer (1974) 0.93
Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet (1992) 0.93
Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. Br J Radiol (1974) 0.93
Chromatin structure and cellular radiosensitivity: a comparison of two human tumour cell lines. Int J Radiat Biol (1996) 0.92
Prognosis after portocaval anastomosis: a 15-year follow-up. Br J Surg (1975) 0.90
Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo. Int J Radiat Oncol Biol Phys (1986) 0.90
Acetylcholine responses in L cells. Science (1972) 0.90
Radioprotection by pentobarbitone sodium of a murine tumour in vivo. Int J Radiat Biol Relat Stud Phys Chem Med (1977) 0.90
Why are some human tumours more radiosensitive than others? Radiother Oncol (1989) 0.89
Regulation of acetylcholine receptor levels by a cholinergic agonist in mouse muscle cell cultures. Proc Natl Acad Sci U S A (1978) 0.89
Pulsed Doppler angiography in lower limb arterial ischemia. Surgery (1979) 0.89
Glutathione determination by the Tietze enzymatic recycling assay and its relationship to cellular radiation response. Br J Cancer (1995) 0.89
The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice. Int J Radiat Oncol Biol Phys (1982) 0.88
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities. Int J Cancer (2000) 0.88
Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds. Br J Cancer (1982) 0.88
Action of actinomycin D, bleomycin and x rays on HeLa cells. Br J Radiol (1973) 0.87
Hypothermic low flow liver perfusion as a means of porcine hepatic storage for six hours. Br J Surg (1968) 0.87
Induction of hypoxia in normal and malignant tissues by changing the oxygen affinity of hemoglobin--implications for therapy. Int J Radiat Oncol Biol Phys (1986) 0.86
A case of Alzheimer's disease and hippocampal sclerosis with normal cholinergic activity in basal forebrain, neocortex, and hippocampus. Neurology (1989) 0.85
The relative cellular radiosensitivity of 30 human in vitro cell lines of different histological type to high LET 62.5 MeV (p-->Be+) fast neutrons and 4 MeV photons. Radiother Oncol (1994) 0.85
A transportable apparatus for liver preservation. Eur Surg Res (1970) 0.85
Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int J Radiat Biol (1996) 0.85
Heterogeneity of radiosensitivity in a human glioma cell line. Int J Radiat Oncol Biol Phys (1992) 0.85
Recognition and prevention of intraoperative warm-ischaemia in liver transplantation. Br Med J (1968) 0.85
Transmission on an active electrical response between fibroblasts (L cells) in cell culture. J Gen Physiol (1973) 0.84
An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI). Int J Radiat Oncol Biol Phys (1982) 0.84
The effect of irradiating a transplanted solid sarcoma on the subsequent development of metastases. Br J Cancer (1974) 0.84
In vitro microdialysis: a novel technique for stimulated neurotransmitter release measurements. J Neurosci Methods (1991) 0.84
Clonal variation in the sensitivity of B16 melanoma to m-AMSA. Br J Cancer (1982) 0.84
Molecular determinants of radiosensitivity in mammalian cells. Int J Radiat Biol (1994) 0.83
Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours. Br J Cancer (1984) 0.83
Thiol reactive nitroimidazoles: radiosensitization studies in vitro and in vivo. Int J Radiat Biol Relat Stud Phys Chem Med (1984) 0.83
DNA damage and prediction of radiation response in lymphocytes and epidermal skin human cells. Int J Cancer (1998) 0.83
Response of two mouse tumours to hyperthermia with CCNU or melphalan. Br J Cancer (1982) 0.83